-The Telegraph New Delhi: An industry body and medical experts have decried a government proposal to replace gelatin with cellulose to encapsulate drugs, calling it an impractical idea that needlessly injects the vegetarian-non-vegetarian debate into medicines. The Punjab Haryana Delhi (PHD) Chamber of Commerce and industry today said gelatin had been used for over a century and made up 95 per cent of capsule formulations worldwide, and cautioned that the proposal to...

-The Hindu Our education system has failed to integrate the rural into the larger political community, the nation Rural Mandsaur, where five persons were killed during a demonstration recently, is a prosperous region of western Madhya Pradesh. More than a decade ago, I had the opportunity of spending two days with the children of a private residential school in Mandsaur. At that time, it was the only English-medium residential school. Its vast and...

-The Financial Express If you are a risk-averse investor and have been banking on small savings schemes for the purpose of saving and investment as well as building your retirement nest egg, then there is some bad news for you. For, the government has reduced the return on small savings schemes – including Public Provident Fund (PPF), NSC, Kisan Vikas Patra and Senior Citizen Savings Scheme — by 10 basis points....

-The Hindu The long-term benefits of GST are clear — the challenge is to quickly address the short-term obstacles The Goods and Services Tax (GST) is in force from today. The reform, touted as a “game changer” and the “reform of the century”, was deemed worthy of a launch on the midnight of June 30 in the Central Hall of the Parliament. Indeed, one is reminded of the famous speech by Pandit...

-The Telegraph New Delhi: India's drug pricing rules allow companies to inflate the maximum retail prices of medicines, including life-saving drugs, costing patients thousands of additional rupees while offering slices of the profits to stockists, chemists, and hospitals. Quotations received by hospitals from drug companies' representatives offering discounts on maximum retail prices (MRPs) of medicines provide what some doctors and patients' rights advocates say is fresh evidence for excessive profiteering in India's...